Pub Date : 2025-10-01Epub Date: 2025-05-14DOI: 10.1097/FM9.0000000000000285
Zhuo Ren, Xinping Sun, Zhi Li, Huixia Yang
{"title":"Vaginal Bleeding After Pregnancy: Progesterone Levels and Pregnancy Outcomes in the First Trimester.","authors":"Zhuo Ren, Xinping Sun, Zhi Li, Huixia Yang","doi":"10.1097/FM9.0000000000000285","DOIUrl":"10.1097/FM9.0000000000000285","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"256-257"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-05-23DOI: 10.1097/FM9.0000000000000293
Hongbo Qi
{"title":"A Century of Legacy: Charting New Frontiers in Maternal-Fetal Medicine.","authors":"Hongbo Qi","doi":"10.1097/FM9.0000000000000293","DOIUrl":"10.1097/FM9.0000000000000293","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"193-194"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-08-05DOI: 10.1097/FM9.0000000000000307
Fang He, Dunjin Chen
{"title":"Development and Future Perspectives of Obstetric Intensive Care Units in China.","authors":"Fang He, Dunjin Chen","doi":"10.1097/FM9.0000000000000307","DOIUrl":"10.1097/FM9.0000000000000307","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"195-199"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Observation of a Rare Binder Phenotype With Fetal Overgrowth Due to a <i>SPIN4</i> Mutation.","authors":"Noopur Chawla, Meenakshi Rajput, Rhea Shriyan, Sumitra Bachani, Aprajita Gupta","doi":"10.1097/FM9.0000000000000298","DOIUrl":"10.1097/FM9.0000000000000298","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"258-259"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-09-22DOI: 10.1097/FM9.0000000000000314
Made Favian Budi Gunawan, Cindy Thiovany Soetomo, Richard Richard, Putu Bagus Darmayasa, Arresta Vitasatria Suastika
Objective: To evaluate the safety and effectiveness of intermittent bolus administration of ephedrine, norepinephrine, and phenylephrine in the treatment of maternal hypotension during spinal anesthesia for cesarean sections in preeclamptic women.
Methods: This PRISMA-based systematic review included English random control trails (RCTs) of women with singleton preeclampsia (American College of Obstetricians and Gynecologists (ACOG) criteria) undergoing cesarean delivery with spinal anesthesia, excluding chronic hypertension or systemic disease. Interventions were intermittent bolus phenylephrine, norepinephrine, or ephedrine, with outcomes on maternal hemodynamics, neonatal status, and adverse events. Searches of PubMed, ScienceDirect, Google Scholar, and Cochrane (to December 2024) plus reference screening identified eligible studies. Two reviewers independently selected studies, extracted data, and assessed risk of bias (Cochrane RoB 2.0). Due to heterogeneity in vasopressor regimens and outcome measures, results were synthesized narratively.
Results: Of 2333 records screened, six RCTs (sample sizes 20-166) were included, all in preeclamptic women undergoing cesarean delivery. Overall risk of bias was low. Norepinephrine better preserved maternal hemodynamics than phenylephrine or ephedrine, with higher cardiac output (6.31 ± 1.08 vs. 5.45 ± 1.21 L/min; P = 0.009) and lower uteroplacental resistance (0.04 ± 0.02 vs. 0.06 ± 0.03; P = 0.002). Ephedrine caused higher heart rates (84.9 ± 7.1 vs. 76.6 ± 6.9 bpm; P < 0.05) and more nausea/vomiting. Neonatal umbilical artery pH was higher with norepinephrine or phenylephrine than ephedrine (7.32 ± 0.02 vs. 7.31 ± 0.03; P < 0.050), while Apgar scores did not differ. Adverse events favored norepinephrine, which reduced bradycardia versus phenylephrine (5.1% vs. 20.5%; relative risk (RR) = 0.25; P = 0.042) and tachycardia versus ephedrine (16.1% vs. 36.4%; RR = 0.54; P = 0.020).
Conclusion: Intermittent bolus administration of norepinephrine offers superior maternal cardiac output and neonatal safety, making it optimal for preeclamptic cesarean deliveries. Phenylephrine is effective for blood pressure control but may induce bradycardia, while the use of ephedrine is limited by its association with neonatal acidosis. Tailored vasopressor selection is thus essential for optimal outcomes.
Registration: PROSPERO; CRD42024565007.
目的:评价麻黄素、去甲肾上腺素、苯肾上腺素间歇给药治疗子痫前期剖宫产腰麻产妇低血压的安全性和有效性。方法:这项基于prisma的系统评价纳入了接受脊髓麻醉剖宫产的单胎子痫前期妇女(美国妇产科学院(ACOG)标准)的英文随机对照试验(rct),排除慢性高血压或全身性疾病。干预措施是间歇性地服用苯肾上腺素、去甲肾上腺素或麻黄素,对产妇血流动力学、新生儿状态和不良事件有影响。检索PubMed, ScienceDirect, b谷歌Scholar和Cochrane(截至2024年12月),加上参考筛选,确定了符合条件的研究。两位审稿人独立选择研究、提取数据并评估偏倚风险(Cochrane RoB 2.0)。由于血管加压疗法和结果测量的异质性,结果是叙述性的。结果:在筛选的2333条记录中,包括6项随机对照试验(样本量20-166),均为剖宫产的先兆子痫妇女。总体偏倚风险较低。去甲肾上腺素比苯肾上腺素和麻黄碱能更好地保护母体血流动力学,心输出量更高(6.31±1.08比5.45±1.21 L/min; P = 0.009),子宫胎盘阻力更低(0.04±0.02比0.06±0.03;P = 0.002)。麻黄碱导致心率升高(84.9±7.1比76.6±6.9 bpm; P < 0.05)和恶心/呕吐加重。去甲肾上腺素和苯肾上腺素组新生儿脐动脉pH值高于麻黄素组(7.32±0.02比7.31±0.03;P < 0.050),而Apgar评分差异无统计学意义。不良事件倾向于去甲肾上腺素,与苯肾上腺素相比,去甲肾上腺素可减少心动过缓(5.1%对20.5%;相对危险度(RR) = 0.25;P = 0.042)和心动过速与麻黄碱(16.1%比36.4%;RR = 0.54; P = 0.020)。结论:间歇给药去甲肾上腺素可提高产妇心输出量和新生儿安全性,是子痫前期剖宫产的最佳选择。苯肾上腺素对血压控制有效,但可能引起心动过缓,而麻黄碱的使用因其与新生儿酸中毒有关而受到限制。因此,量身定制的血管加压剂选择对于获得最佳结果至关重要。注册:普洛斯彼罗;CRD42024565007。
{"title":"Dissecting Vasopressor Efficacy in the Management of Maternal Hypotension in Preeclamptic Cesarean Delivery: A Systematic Review of Randomized Controlled Trials.","authors":"Made Favian Budi Gunawan, Cindy Thiovany Soetomo, Richard Richard, Putu Bagus Darmayasa, Arresta Vitasatria Suastika","doi":"10.1097/FM9.0000000000000314","DOIUrl":"10.1097/FM9.0000000000000314","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the safety and effectiveness of intermittent bolus administration of ephedrine, norepinephrine, and phenylephrine in the treatment of maternal hypotension during spinal anesthesia for cesarean sections in preeclamptic women.</p><p><strong>Methods: </strong>This PRISMA-based systematic review included English random control trails (RCTs) of women with singleton preeclampsia (American College of Obstetricians and Gynecologists (ACOG) criteria) undergoing cesarean delivery with spinal anesthesia, excluding chronic hypertension or systemic disease. Interventions were intermittent bolus phenylephrine, norepinephrine, or ephedrine, with outcomes on maternal hemodynamics, neonatal status, and adverse events. Searches of PubMed, ScienceDirect, Google Scholar, and Cochrane (to December 2024) plus reference screening identified eligible studies. Two reviewers independently selected studies, extracted data, and assessed risk of bias (Cochrane RoB 2.0). Due to heterogeneity in vasopressor regimens and outcome measures, results were synthesized narratively.</p><p><strong>Results: </strong>Of 2333 records screened, six RCTs (sample sizes 20-166) were included, all in preeclamptic women undergoing cesarean delivery. Overall risk of bias was low. Norepinephrine better preserved maternal hemodynamics than phenylephrine or ephedrine, with higher cardiac output (6.31 ± 1.08 <i>vs</i>. 5.45 ± 1.21 L/min; <i>P</i> = 0.009) and lower uteroplacental resistance (0.04 ± 0.02 <i>vs</i>. 0.06 ± 0.03; <i>P</i> = 0.002). Ephedrine caused higher heart rates (84.9 ± 7.1 <i>vs</i>. 76.6 ± 6.9 bpm; <i>P</i> < 0.05) and more nausea/vomiting. Neonatal umbilical artery pH was higher with norepinephrine or phenylephrine than ephedrine (7.32 ± 0.02 <i>vs</i>. 7.31 ± 0.03; <i>P</i> < 0.050), while Apgar scores did not differ. Adverse events favored norepinephrine, which reduced bradycardia versus phenylephrine (5.1% <i>vs</i>. 20.5%; relative risk (<i>RR</i>) = 0.25; <i>P</i> = 0.042) and tachycardia versus ephedrine (16.1% <i>vs</i>. 36.4%; <i>RR</i> = 0.54; <i>P</i> = 0.020).</p><p><strong>Conclusion: </strong>Intermittent bolus administration of norepinephrine offers superior maternal cardiac output and neonatal safety, making it optimal for preeclamptic cesarean deliveries. Phenylephrine is effective for blood pressure control but may induce bradycardia, while the use of ephedrine is limited by its association with neonatal acidosis. Tailored vasopressor selection is thus essential for optimal outcomes.</p><p><strong>Registration: </strong>PROSPERO; CRD42024565007.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"234-243"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558338/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-08-15DOI: 10.1097/FM9.0000000000000311
Fanglan Luo, Qinsheng Lu, Wei Wei, Yingmei Cen, Yinchun Huang, Shuang Qin, Chunjiao Wei, Gendie E Lash, Li Li
Objective: To evaluate the early pregnancy loss (EPL) rates in women with and without low molecular weight heparin (LMWH) treatment during early pregnancy.
Methods: A retrospective, non-randomized study was conducted at Guangzhou Women and Children's Medical Center between June 2019 and March 2022, involving women diagnosed with polycystic ovary syndrome (PCOS). All participants conceived following standard preconception care and voluntarily chose either the control group or the LMWH intervention group during the first month of pregnancy. The intervention was administered throughout the entire first trimester. Early and final pregnancy outcomes were recorded, with a particular focus on EPL rates. In addition, venous blood samples and clinical data were collected to compare hormonal profiles, blood lipid levels, and anthropometric parameters between the two groups. Statistical analyses included the two-tailed unpaired Student's t-test, Mann-Whitney U test, Chi-square test, and Kaplan-Meier survival analysis. A value of P < 0.050 was considered statistically significant.
Results: Thirty-eight women in the LMWH group and 102 women in the control group were included. The EPL rates in the LMWH and control groups were 5.3% (2/38) and 26.5% (27/102), respectively (χ2 = 7.582, P = 0.006, odds ratio (OR) = 0.154, 95% confidence interval (CI): 0.035-0.685). The age (P = 0.005), PCOS subtype (P = 0.012), and levels of total cholesterol (P = 0.003), and high-density lipoprotein (P = 0.018) were significantly different between these two groups. Continued follow-up was performed to observe the long-time effects of LMWH treatment in early pregnancy. Seventy-three patients were successfully delivered, 23 patients in the LMWH group and 50 patients in the control group. There was no significant difference between the LMWH and control groups in gestation length, bleeding during delivery, birth weight, gender of the newborn, or mode of delivery. In addition, Kaplan-Meier curve analysis revealed that LMWH treatment may decrease the risk of EPL in PCOS patients in the first trimester (χ2 = 4.144, P = 0.040).
Conclusion: LMWH treatment during early pregnancy may reduce the EPL rate in women with PCOS.
{"title":"Effects of Low Molecular Weight Heparin on Early Pregnancy Loss in Women With Polycystic Ovary Syndrome.","authors":"Fanglan Luo, Qinsheng Lu, Wei Wei, Yingmei Cen, Yinchun Huang, Shuang Qin, Chunjiao Wei, Gendie E Lash, Li Li","doi":"10.1097/FM9.0000000000000311","DOIUrl":"10.1097/FM9.0000000000000311","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the early pregnancy loss (EPL) rates in women with and without low molecular weight heparin (LMWH) treatment during early pregnancy.</p><p><strong>Methods: </strong>A retrospective, non-randomized study was conducted at Guangzhou Women and Children's Medical Center between June 2019 and March 2022, involving women diagnosed with polycystic ovary syndrome (PCOS). All participants conceived following standard preconception care and voluntarily chose either the control group or the LMWH intervention group during the first month of pregnancy. The intervention was administered throughout the entire first trimester. Early and final pregnancy outcomes were recorded, with a particular focus on EPL rates. In addition, venous blood samples and clinical data were collected to compare hormonal profiles, blood lipid levels, and anthropometric parameters between the two groups. Statistical analyses included the two-tailed unpaired Student's <i>t</i>-test, Mann-Whitney <i>U</i> test, Chi-square test, and Kaplan-Meier survival analysis. A value of <i>P</i> < 0.050 was considered statistically significant.</p><p><strong>Results: </strong>Thirty-eight women in the LMWH group and 102 women in the control group were included. The EPL rates in the LMWH and control groups were 5.3% (2/38) and 26.5% (27/102), respectively (<i>χ</i> <sup>2</sup> = 7.582, <i>P</i> = 0.006, odds ratio (<i>OR</i>) = 0.154, 95% confidence interval (<i>CI</i>): 0.035-0.685). The age (<i>P</i> = 0.005), PCOS subtype (<i>P</i> = 0.012), and levels of total cholesterol (<i>P</i> = 0.003), and high-density lipoprotein (<i>P</i> = 0.018) were significantly different between these two groups. Continued follow-up was performed to observe the long-time effects of LMWH treatment in early pregnancy. Seventy-three patients were successfully delivered, 23 patients in the LMWH group and 50 patients in the control group. There was no significant difference between the LMWH and control groups in gestation length, bleeding during delivery, birth weight, gender of the newborn, or mode of delivery. In addition, Kaplan-Meier curve analysis revealed that LMWH treatment may decrease the risk of EPL in PCOS patients in the first trimester (<i>χ</i> <sup>2</sup> = 4.144, <i>P</i> = 0.040).</p><p><strong>Conclusion: </strong>LMWH treatment during early pregnancy may reduce the EPL rate in women with PCOS.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"200-207"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558281/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To evaluate the diagnostic efficacy and clinical application of the Obstetrical Chinese Disseminated Intravascular Coagulation (DIC) Scoring System (OCDSS).
Methods: This study is a retrospective study that collected 1063 cases from Wuhan Union Hospital, Yichang Central People's Hospital, and the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture between July 2017 and June 2024. These cases were divided into DIC and non-DIC groups based on score standard. Diagnosis of DIC, the rate of hysterectomy, neonatal mortality, and severe asphyxia are the main outcome measures. All the laboratory indicators are all determined by clinical laboratory department of the hospital. Data were expressed as mean ± standard deviation or median (interquartile range) and frequencies. Independent sample t-test or non-parametric test were used to compare measurement data, while the chi-square test was used for count data. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used to test the predictive accuracy. Using univariate and multivariate logistic regression analysis to study the high-risk factors. P < 0.050 indicates a statistical significance.
Results: Of 1063 participants in this study, 29 participants (2.73%) were diagnosed with obstetrical DIC by OCDSS score standard, and all the participants were diagnosed as DIC with underlying disease. When the Takao, Clark, and Erez score standard is the "gold standard", the OCDSS score standard always shows good sensitivity and specificity, with all the AUC over 0.75. OCDSS score standard also has better predictive of hysterectomy (68.18%, 91.07%, 0.872), severe neonatal asphyxia and death (79.17%, 75.07%, 0.842) than the other three score standards. All the indicators included in the OCDSS score standard contributed to the DIC diagnosis (all the P < 0.001). The indicators in the DIC group were more abnormal than the non-DIC group (all the P < 0.001).
Conclusion: OCDSS is a first score standard, especially for pregnancies, it considers the underlying disease, clinical symptoms, and laboratory results. This score system shared a good diagnosis performance for DIC in the Chinese population and may help clinicians make timely decisions.
{"title":"Multicenter Retrospective Evaluation of the Chinese Expert Consensus Scoring System for the Diagnosis of Obstetrical DIC.","authors":"Jianjian Cui, Ziyang Liu, Wencong He, Ruifen Su, Ruilin Ma, Hui Tao, Zejun Yang, Lei Sun, Shaoqi Chen, Yanan Li, Zhishan Jin, Yin Zhao","doi":"10.1097/FM9.0000000000000313","DOIUrl":"10.1097/FM9.0000000000000313","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the diagnostic efficacy and clinical application of the Obstetrical Chinese Disseminated Intravascular Coagulation (DIC) Scoring System (OCDSS).</p><p><strong>Methods: </strong>This study is a retrospective study that collected 1063 cases from Wuhan Union Hospital, Yichang Central People's Hospital, and the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture between July 2017 and June 2024. These cases were divided into DIC and non-DIC groups based on score standard. Diagnosis of DIC, the rate of hysterectomy, neonatal mortality, and severe asphyxia are the main outcome measures. All the laboratory indicators are all determined by clinical laboratory department of the hospital. Data were expressed as mean ± standard deviation or median (interquartile range) and frequencies. Independent sample <i>t</i>-test or non-parametric test were used to compare measurement data, while the chi-square test was used for count data. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used to test the predictive accuracy. Using univariate and multivariate logistic regression analysis to study the high-risk factors. <i>P</i> < 0.050 indicates a statistical significance.</p><p><strong>Results: </strong>Of 1063 participants in this study, 29 participants (2.73%) were diagnosed with obstetrical DIC by OCDSS score standard, and all the participants were diagnosed as DIC with underlying disease. When the Takao, Clark, and Erez score standard is the \"gold standard\", the OCDSS score standard always shows good sensitivity and specificity, with all the AUC over 0.75. OCDSS score standard also has better predictive of hysterectomy (68.18%, 91.07%, 0.872), severe neonatal asphyxia and death (79.17%, 75.07%, 0.842) than the other three score standards. All the indicators included in the OCDSS score standard contributed to the DIC diagnosis (all the <i>P</i> < 0.001). The indicators in the DIC group were more abnormal than the non-DIC group (all the <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>OCDSS is a first score standard, especially for pregnancies, it considers the underlying disease, clinical symptoms, and laboratory results. This score system shared a good diagnosis performance for DIC in the Chinese population and may help clinicians make timely decisions.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"216-227"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-08-25DOI: 10.1097/FM9.0000000000000300
Shelby Masters, Shihyun Kim, Elena Moses, Ashelee Mcmanaman, Bipin Ghimire, Gregory Goyert
{"title":"Stage IV Pancreatic Adenocarcinoma in Pregnancy.","authors":"Shelby Masters, Shihyun Kim, Elena Moses, Ashelee Mcmanaman, Bipin Ghimire, Gregory Goyert","doi":"10.1097/FM9.0000000000000300","DOIUrl":"10.1097/FM9.0000000000000300","url":null,"abstract":"","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"263-264"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To assess the impact of maternal physiological and pathological factors on fetal birth weight in pregnancies in Kazakhstan.
Methods: This retrospective cross-sectional study was conducted from January 2016 to December 2021 at Aksu City Hospital, Atyrau Regional Perinatal Center, Altai Interdistrict Hospital, Abay Regional Perinatal Center of the Health Department, and Astana Multidisciplinary City Hospital No. 3, in the Republic of Kazakhstan using the stratified randomization grouping method. The study involved two maternal ethnicity groups, Asian (5101; 77.91%) and European (1446; 22.09%). All statistical analyses were performed using Stat Tech version 3.0.9 and SPSS 26.0.
Results: This study involved 6547 pregnant women. Fetuses weighing < 2500 g were more common in the Asian group than in the European one (P = 0.001), while large fetuses (> 4000 g) were more common in the European group (P = 0.001). Multiple linear regression analyses revealed that a history of arterial hypertension and preeclampsia leads to decreased fetal weight, while gestational diabetes mellitus (GDM) was associated with increased fetal weight. In the Asian ethnic group, maternal physiological factors and a history of arterial hypertension, preeclampsia, and GDM significantly influenced fetal birth weight. In the European group, a history of hypertension and GDM did not affect birth weight.
Conclusion: Stillbirth and perinatal death were more likely among women of the Asian ethnic group when compared with women of the European ethnic group. Therefore, it is necessary to account for the maternal physiological and pathological factors that may influence fetal birth weight when assessing optimal fetal birth weight.
{"title":"Customized Birthweight Standard for the Population in the Republic of Kazakhstan.","authors":"Meruyert Sharipova, Gulyash Tanysheva, Khalida Sharipova, Bologan Ion, Aizhan Shakhanova","doi":"10.1097/FM9.0000000000000309","DOIUrl":"10.1097/FM9.0000000000000309","url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of maternal physiological and pathological factors on fetal birth weight in pregnancies in Kazakhstan.</p><p><strong>Methods: </strong>This retrospective cross-sectional study was conducted from January 2016 to December 2021 at Aksu City Hospital, Atyrau Regional Perinatal Center, Altai Interdistrict Hospital, Abay Regional Perinatal Center of the Health Department, and Astana Multidisciplinary City Hospital No. 3, in the Republic of Kazakhstan using the stratified randomization grouping method. The study involved two maternal ethnicity groups, Asian (5101; 77.91%) and European (1446; 22.09%). All statistical analyses were performed using Stat Tech version 3.0.9 and SPSS 26.0.</p><p><strong>Results: </strong>This study involved 6547 pregnant women. Fetuses weighing < 2500 g were more common in the Asian group than in the European one (<i>P</i> = 0.001), while large fetuses (> 4000 g) were more common in the European group (<i>P</i> = 0.001). Multiple linear regression analyses revealed that a history of arterial hypertension and preeclampsia leads to decreased fetal weight, while gestational diabetes mellitus (GDM) was associated with increased fetal weight. In the Asian ethnic group, maternal physiological factors and a history of arterial hypertension, preeclampsia, and GDM significantly influenced fetal birth weight. In the European group, a history of hypertension and GDM did not affect birth weight.</p><p><strong>Conclusion: </strong>Stillbirth and perinatal death were more likely among women of the Asian ethnic group when compared with women of the European ethnic group. Therefore, it is necessary to account for the maternal physiological and pathological factors that may influence fetal birth weight when assessing optimal fetal birth weight.</p>","PeriodicalId":74121,"journal":{"name":"Maternal-fetal medicine (Wolters Kluwer Health, Inc.)","volume":"7 4","pages":"208-215"},"PeriodicalIF":1.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12558212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145395768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}